Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperglycemia | 13 | 2022 | 1389 | 3.230 |
Why?
|
Fatigue | 44 | 2024 | 1556 | 3.110 |
Why?
|
Nursing Research | 8 | 2023 | 80 | 3.100 |
Why?
|
Neoplasms | 104 | 2024 | 22386 | 3.090 |
Why?
|
Informed Consent | 6 | 2019 | 1012 | 1.820 |
Why?
|
Antineoplastic Agents | 45 | 2024 | 13708 | 1.480 |
Why?
|
Genital Neoplasms, Female | 6 | 2024 | 539 | 1.290 |
Why?
|
Quality of Life | 40 | 2024 | 13497 | 1.270 |
Why?
|
Gastrointestinal Neoplasms | 9 | 2023 | 959 | 1.240 |
Why?
|
Biomedical Research | 6 | 2017 | 3463 | 1.090 |
Why?
|
Outpatients | 25 | 2024 | 1607 | 1.090 |
Why?
|
Stress, Psychological | 21 | 2024 | 4538 | 1.070 |
Why?
|
Moral Obligations | 2 | 2017 | 91 | 1.060 |
Why?
|
Morals | 3 | 2017 | 289 | 1.020 |
Why?
|
Blood Glucose | 8 | 2022 | 6429 | 0.920 |
Why?
|
Hypoglycemia | 3 | 2020 | 894 | 0.850 |
Why?
|
Nausea | 9 | 2024 | 682 | 0.770 |
Why?
|
Nursing Staff | 1 | 2022 | 113 | 0.760 |
Why?
|
Ethics, Research | 3 | 2017 | 177 | 0.740 |
Why?
|
Breast Neoplasms | 21 | 2024 | 21156 | 0.720 |
Why?
|
Resilience, Psychological | 9 | 2024 | 804 | 0.700 |
Why?
|
Colonic Neoplasms | 2 | 2022 | 2544 | 0.690 |
Why?
|
Syndrome | 15 | 2024 | 3278 | 0.650 |
Why?
|
Nursing Process | 1 | 2019 | 17 | 0.650 |
Why?
|
Nursing Staff, Hospital | 1 | 2022 | 350 | 0.640 |
Why?
|
Hematopoietic Stem Cell Transplantation | 7 | 2023 | 5709 | 0.640 |
Why?
|
Anxiety | 18 | 2024 | 4655 | 0.640 |
Why?
|
Ethics | 1 | 2019 | 94 | 0.630 |
Why?
|
Comorbidity | 17 | 2024 | 10601 | 0.610 |
Why?
|
Peripheral Nervous System Diseases | 6 | 2024 | 716 | 0.590 |
Why?
|
Data Collection | 2 | 2017 | 3329 | 0.590 |
Why?
|
Adaptation, Psychological | 10 | 2024 | 2665 | 0.570 |
Why?
|
Pain | 15 | 2024 | 5096 | 0.540 |
Why?
|
Humans | 181 | 2024 | 768451 | 0.530 |
Why?
|
Paclitaxel | 5 | 2024 | 1737 | 0.510 |
Why?
|
Nurse's Role | 4 | 2023 | 188 | 0.500 |
Why?
|
Patient Rights | 1 | 2016 | 127 | 0.500 |
Why?
|
Lymphedema | 4 | 2024 | 527 | 0.490 |
Why?
|
Female | 116 | 2024 | 396943 | 0.480 |
Why?
|
Hematologic Diseases | 2 | 2016 | 499 | 0.480 |
Why?
|
Longitudinal Studies | 32 | 2024 | 14766 | 0.470 |
Why?
|
Authorship | 1 | 2017 | 287 | 0.460 |
Why?
|
Research Personnel | 2 | 2023 | 591 | 0.450 |
Why?
|
Middle Aged | 77 | 2024 | 223418 | 0.450 |
Why?
|
Exercise Therapy | 1 | 2021 | 941 | 0.440 |
Why?
|
Walking | 1 | 2021 | 1202 | 0.430 |
Why?
|
Depression | 20 | 2024 | 8235 | 0.430 |
Why?
|
Guidelines as Topic | 2 | 2016 | 1395 | 0.420 |
Why?
|
Confidentiality | 1 | 2017 | 606 | 0.410 |
Why?
|
Self Report | 9 | 2024 | 3771 | 0.410 |
Why?
|
Nurses | 1 | 2022 | 2494 | 0.410 |
Why?
|
Medical Oncology | 5 | 2023 | 2347 | 0.410 |
Why?
|
Adult | 59 | 2024 | 223542 | 0.390 |
Why?
|
Antiemetics | 4 | 2022 | 188 | 0.390 |
Why?
|
Interprofessional Relations | 1 | 2017 | 997 | 0.380 |
Why?
|
Male | 81 | 2024 | 364781 | 0.360 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1464 | 0.360 |
Why?
|
Statistics as Topic | 1 | 2017 | 2362 | 0.360 |
Why?
|
Dyspnea | 5 | 2024 | 1352 | 0.360 |
Why?
|
Publishing | 1 | 2017 | 836 | 0.350 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 8051 | 0.350 |
Why?
|
Patients | 6 | 2024 | 909 | 0.350 |
Why?
|
Hematologic Neoplasms | 3 | 2019 | 1905 | 0.340 |
Why?
|
Aged | 49 | 2024 | 171520 | 0.330 |
Why?
|
Patient Selection | 2 | 2020 | 4266 | 0.320 |
Why?
|
Information Dissemination | 1 | 2017 | 1138 | 0.310 |
Why?
|
Societies, Nursing | 2 | 2019 | 22 | 0.300 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 12242 | 0.290 |
Why?
|
Factor Analysis, Statistical | 8 | 2021 | 1007 | 0.270 |
Why?
|
Severity of Illness Index | 18 | 2024 | 15965 | 0.270 |
Why?
|
Circadian Rhythm | 5 | 2023 | 2585 | 0.270 |
Why?
|
Activities of Daily Living | 2 | 2017 | 2433 | 0.270 |
Why?
|
Genome, Human | 1 | 2019 | 4453 | 0.250 |
Why?
|
Diarrhea | 3 | 2024 | 1320 | 0.250 |
Why?
|
Aged, 80 and over | 15 | 2024 | 59680 | 0.250 |
Why?
|
Practice Guidelines as Topic | 3 | 2019 | 7451 | 0.250 |
Why?
|
Potassium Channels | 2 | 2024 | 538 | 0.240 |
Why?
|
Photoperiod | 2 | 2015 | 141 | 0.230 |
Why?
|
Genomics | 2 | 2021 | 5909 | 0.230 |
Why?
|
Research Design | 6 | 2023 | 6217 | 0.230 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16029 | 0.230 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2021 | 2040 | 0.220 |
Why?
|
Vomiting | 2 | 2024 | 655 | 0.220 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26351 | 0.200 |
Why?
|
Parents | 1 | 2016 | 3596 | 0.200 |
Why?
|
Vincristine | 1 | 2024 | 1039 | 0.200 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2019 | 475 | 0.190 |
Why?
|
Cyclophosphamide | 2 | 2019 | 2224 | 0.190 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2024 | 624 | 0.190 |
Why?
|
Taste | 2 | 2020 | 191 | 0.190 |
Why?
|
Cannabidiol | 1 | 2023 | 123 | 0.190 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5367 | 0.190 |
Why?
|
Ovarian Neoplasms | 3 | 2024 | 4906 | 0.190 |
Why?
|
Holistic Nursing | 1 | 2021 | 3 | 0.190 |
Why?
|
Evidence-Based Nursing | 1 | 2021 | 13 | 0.190 |
Why?
|
Adenosine Monophosphate | 1 | 2022 | 233 | 0.180 |
Why?
|
Cytokines | 5 | 2024 | 7449 | 0.180 |
Why?
|
Pediatrics | 1 | 2016 | 3622 | 0.180 |
Why?
|
Psychological Tests | 1 | 2023 | 643 | 0.180 |
Why?
|
Chronic Disease | 2 | 2015 | 9382 | 0.180 |
Why?
|
Models, Biological | 2 | 2019 | 9505 | 0.180 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2022 | 3550 | 0.180 |
Why?
|
Nursing Care | 1 | 2021 | 65 | 0.180 |
Why?
|
Cough | 1 | 2024 | 598 | 0.170 |
Why?
|
Neurotransmitter Agents | 1 | 2024 | 666 | 0.170 |
Why?
|
Cost of Illness | 4 | 2024 | 1960 | 0.170 |
Why?
|
Risk Factors | 21 | 2024 | 74915 | 0.170 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13589 | 0.170 |
Why?
|
Saliva | 1 | 2024 | 854 | 0.160 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3826 | 0.160 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2020 | 193 | 0.160 |
Why?
|
DNA Methylation | 4 | 2023 | 4421 | 0.160 |
Why?
|
Loneliness | 1 | 2021 | 207 | 0.150 |
Why?
|
Job Satisfaction | 1 | 2022 | 549 | 0.150 |
Why?
|
Cluster Analysis | 5 | 2024 | 2731 | 0.150 |
Why?
|
Physical Endurance | 1 | 2020 | 370 | 0.150 |
Why?
|
Organizational Objectives | 1 | 2019 | 427 | 0.150 |
Why?
|
Qualitative Research | 3 | 2023 | 3115 | 0.140 |
Why?
|
Cannabis | 1 | 2023 | 444 | 0.140 |
Why?
|
Respiration Disorders | 1 | 2020 | 367 | 0.140 |
Why?
|
History, 16th Century | 1 | 2016 | 70 | 0.140 |
Why?
|
Transplantation Conditioning | 1 | 2023 | 1598 | 0.130 |
Why?
|
Sleep | 8 | 2023 | 4796 | 0.130 |
Why?
|
History, 17th Century | 1 | 2016 | 109 | 0.130 |
Why?
|
Forecasting | 2 | 2016 | 2950 | 0.130 |
Why?
|
Personality | 1 | 2020 | 558 | 0.130 |
Why?
|
Random Allocation | 1 | 2021 | 2399 | 0.130 |
Why?
|
Preventive Medicine | 1 | 2018 | 245 | 0.130 |
Why?
|
STAT Transcription Factors | 1 | 2017 | 190 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2024 | 1836 | 0.130 |
Why?
|
History, 18th Century | 1 | 2016 | 207 | 0.130 |
Why?
|
Endocytosis | 1 | 2020 | 960 | 0.130 |
Why?
|
Fear | 2 | 2022 | 1494 | 0.130 |
Why?
|
Janus Kinases | 1 | 2017 | 253 | 0.130 |
Why?
|
Ambulatory Care | 3 | 2022 | 2780 | 0.120 |
Why?
|
Axons | 2 | 2024 | 1678 | 0.120 |
Why?
|
Anesthetics, Inhalation | 1 | 2020 | 575 | 0.120 |
Why?
|
Periodicity | 4 | 2020 | 348 | 0.120 |
Why?
|
Models, Theoretical | 1 | 2007 | 3590 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1095 | 0.120 |
Why?
|
United States | 11 | 2024 | 73121 | 0.120 |
Why?
|
Models, Psychological | 1 | 2018 | 835 | 0.120 |
Why?
|
Constipation | 1 | 2019 | 570 | 0.120 |
Why?
|
Interleukin-6 | 1 | 2024 | 3234 | 0.110 |
Why?
|
Cognition | 5 | 2024 | 7066 | 0.110 |
Why?
|
Self Concept | 1 | 2020 | 1050 | 0.110 |
Why?
|
History, 19th Century | 1 | 2016 | 716 | 0.110 |
Why?
|
Perception | 1 | 2020 | 1207 | 0.110 |
Why?
|
Cytoskeleton | 1 | 2019 | 1179 | 0.110 |
Why?
|
Signal Transduction | 6 | 2024 | 23638 | 0.110 |
Why?
|
Leadership | 1 | 2023 | 1395 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11930 | 0.110 |
Why?
|
Inflammation | 2 | 2024 | 10865 | 0.100 |
Why?
|
Fasting | 1 | 2019 | 1608 | 0.100 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2019 | 953 | 0.100 |
Why?
|
Abdominal Pain | 1 | 2019 | 1070 | 0.100 |
Why?
|
NF-kappa B | 2 | 2022 | 2491 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 712 | 0.100 |
Why?
|
Decision Making | 2 | 2016 | 3961 | 0.100 |
Why?
|
Cardiovascular Diseases | 1 | 2018 | 15638 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2561 | 0.100 |
Why?
|
Inflammasomes | 1 | 2017 | 541 | 0.100 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2015 | 618 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2021 | 1764 | 0.090 |
Why?
|
Massachusetts | 1 | 2024 | 8908 | 0.090 |
Why?
|
Caregivers | 1 | 2023 | 2302 | 0.090 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3708 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2015 | 810 | 0.090 |
Why?
|
Physician-Patient Relations | 2 | 2021 | 3267 | 0.090 |
Why?
|
Prevalence | 6 | 2021 | 15880 | 0.090 |
Why?
|
History, 21st Century | 1 | 2016 | 1575 | 0.090 |
Why?
|
Pilot Projects | 2 | 2021 | 8730 | 0.090 |
Why?
|
Social Isolation | 2 | 2024 | 369 | 0.080 |
Why?
|
Nursing Assessment | 1 | 2010 | 106 | 0.080 |
Why?
|
Prediabetic State | 1 | 2015 | 548 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1638 | 0.080 |
Why?
|
Nutrition Disorders | 1 | 2010 | 204 | 0.080 |
Why?
|
Mass Screening | 3 | 2021 | 5455 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 4049 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2659 | 0.080 |
Why?
|
Patient Preference | 1 | 2016 | 948 | 0.080 |
Why?
|
Vaginal Smears | 2 | 2021 | 501 | 0.080 |
Why?
|
History, 20th Century | 1 | 2016 | 2772 | 0.080 |
Why?
|
Health Policy | 1 | 2021 | 2699 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 5887 | 0.070 |
Why?
|
Aging | 1 | 2007 | 8761 | 0.070 |
Why?
|
Communication | 4 | 2024 | 3910 | 0.070 |
Why?
|
Hypesthesia | 2 | 2019 | 106 | 0.070 |
Why?
|
Transplantation Immunology | 1 | 2010 | 538 | 0.070 |
Why?
|
Nursing Theory | 1 | 2007 | 8 | 0.070 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9507 | 0.070 |
Why?
|
Smoking | 1 | 2024 | 9099 | 0.070 |
Why?
|
Patient Participation | 1 | 2016 | 1450 | 0.070 |
Why?
|
Quality of Health Care | 1 | 2022 | 4340 | 0.070 |
Why?
|
Sensation | 2 | 2019 | 337 | 0.070 |
Why?
|
Retrospective Studies | 4 | 2022 | 81834 | 0.070 |
Why?
|
Morbidity | 1 | 2012 | 1760 | 0.070 |
Why?
|
Prescription Drugs | 1 | 2014 | 634 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9425 | 0.070 |
Why?
|
Acute Kidney Injury | 2 | 2016 | 1943 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 776 | 0.060 |
Why?
|
Young Adult | 4 | 2024 | 60045 | 0.060 |
Why?
|
Complementary Therapies | 1 | 2010 | 487 | 0.060 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7863 | 0.060 |
Why?
|
Patient-Centered Care | 3 | 2022 | 1439 | 0.060 |
Why?
|
Individuality | 2 | 2019 | 310 | 0.060 |
Why?
|
Mitochondria | 1 | 2018 | 3672 | 0.060 |
Why?
|
Postoperative Complications | 2 | 2020 | 15880 | 0.060 |
Why?
|
Health Status | 2 | 2016 | 4096 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 3742 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2010 | 904 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9526 | 0.060 |
Why?
|
Adolescent | 5 | 2024 | 89168 | 0.060 |
Why?
|
Body Mass Index | 2 | 2019 | 13030 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2339 | 0.050 |
Why?
|
Gastrointestinal Diseases | 2 | 2024 | 1207 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2896 | 0.050 |
Why?
|
Pandemics | 4 | 2024 | 8753 | 0.050 |
Why?
|
Lymphotoxin-beta | 1 | 2022 | 14 | 0.050 |
Why?
|
Energy Metabolism | 2 | 2024 | 2901 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Weight Gain | 2 | 2024 | 2357 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2834 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
National Institute of Nursing Research (U.S.) | 1 | 2022 | 3 | 0.050 |
Why?
|
Geriatric Assessment | 1 | 2010 | 1422 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18478 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2884 | 0.050 |
Why?
|
Preoperative Period | 1 | 2024 | 564 | 0.050 |
Why?
|
Dominican Republic | 1 | 2021 | 79 | 0.050 |
Why?
|
Gene Expression | 3 | 2020 | 7605 | 0.050 |
Why?
|
Anxiety Disorders | 2 | 2023 | 2754 | 0.050 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3230 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2019 | 4877 | 0.050 |
Why?
|
Ireland | 1 | 2021 | 170 | 0.050 |
Why?
|
Environment | 1 | 2007 | 1126 | 0.050 |
Why?
|
Patient Discharge | 1 | 2014 | 3471 | 0.040 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2022 | 300 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11843 | 0.040 |
Why?
|
NAD | 1 | 2024 | 618 | 0.040 |
Why?
|
Pain Measurement | 2 | 2022 | 3577 | 0.040 |
Why?
|
Nerve Degeneration | 1 | 2024 | 750 | 0.040 |
Why?
|
Exercise | 1 | 2017 | 5940 | 0.040 |
Why?
|
Prospective Studies | 2 | 2021 | 54914 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1439 | 0.040 |
Why?
|
Self Efficacy | 1 | 2024 | 651 | 0.040 |
Why?
|
Germany | 1 | 2021 | 882 | 0.040 |
Why?
|
Emotions | 2 | 2020 | 2773 | 0.040 |
Why?
|
Quarantine | 1 | 2020 | 187 | 0.040 |
Why?
|
Frail Elderly | 1 | 2023 | 774 | 0.040 |
Why?
|
Arm | 1 | 2021 | 590 | 0.040 |
Why?
|
Phenotype | 3 | 2024 | 16712 | 0.040 |
Why?
|
Lymph Node Excision | 1 | 2024 | 1276 | 0.040 |
Why?
|
Caribbean Region | 1 | 2018 | 193 | 0.040 |
Why?
|
Sensory Thresholds | 1 | 2019 | 377 | 0.040 |
Why?
|
Demography | 1 | 2022 | 1643 | 0.030 |
Why?
|
Religion | 1 | 2020 | 377 | 0.030 |
Why?
|
Vibration | 1 | 2019 | 335 | 0.030 |
Why?
|
Latin America | 1 | 2018 | 416 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 758 | 0.030 |
Why?
|
Electric Impedance | 1 | 2021 | 796 | 0.030 |
Why?
|
California | 1 | 2020 | 1444 | 0.030 |
Why?
|
Time Factors | 4 | 2019 | 40271 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2016 | 26395 | 0.030 |
Why?
|
Upper Extremity | 1 | 2021 | 682 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2021 | 1749 | 0.030 |
Why?
|
Income | 1 | 2024 | 1878 | 0.030 |
Why?
|
Psychology | 1 | 2017 | 356 | 0.030 |
Why?
|
Mastectomy | 1 | 2024 | 1852 | 0.030 |
Why?
|
Cohort Studies | 3 | 2020 | 41797 | 0.030 |
Why?
|
Algorithms | 1 | 2016 | 14158 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5880 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2023 | 4834 | 0.030 |
Why?
|
Hemorrhagic Disorders | 1 | 2014 | 34 | 0.030 |
Why?
|
Disease Progression | 3 | 2017 | 13655 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2258 | 0.030 |
Why?
|
Affect | 1 | 2022 | 1498 | 0.030 |
Why?
|
Lung Diseases | 1 | 2024 | 1926 | 0.030 |
Why?
|
Nurse-Patient Relations | 1 | 2014 | 100 | 0.030 |
Why?
|
Infant | 1 | 2016 | 36497 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2465 | 0.030 |
Why?
|
Postural Balance | 1 | 2018 | 638 | 0.030 |
Why?
|
Incidence | 1 | 2012 | 21552 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2024 | 4249 | 0.030 |
Why?
|
Washington | 1 | 2014 | 314 | 0.030 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 3042 | 0.030 |
Why?
|
Child, Preschool | 1 | 2016 | 42623 | 0.030 |
Why?
|
Infection Control | 1 | 2020 | 985 | 0.030 |
Why?
|
Neuralgia | 1 | 2020 | 620 | 0.030 |
Why?
|
Actins | 1 | 2020 | 2064 | 0.030 |
Why?
|
Educational Status | 1 | 2020 | 2519 | 0.030 |
Why?
|
Family | 1 | 2023 | 3208 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1971 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2020 | 1409 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2020 | 65409 | 0.020 |
Why?
|
Life Change Events | 1 | 2017 | 964 | 0.020 |
Why?
|
Body Composition | 1 | 2021 | 2455 | 0.020 |
Why?
|
Heart Diseases | 1 | 2024 | 2816 | 0.020 |
Why?
|
Social Support | 1 | 2021 | 2195 | 0.020 |
Why?
|
Attention | 1 | 2021 | 2423 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2021 | 4362 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3335 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 500 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2020 | 1309 | 0.020 |
Why?
|
Prefrontal Cortex | 1 | 2020 | 2251 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4630 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3123 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2020 | 5803 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1763 | 0.020 |
Why?
|
Causality | 1 | 2014 | 1255 | 0.020 |
Why?
|
Survivors | 1 | 2019 | 2381 | 0.020 |
Why?
|
Prognosis | 1 | 2009 | 30028 | 0.020 |
Why?
|
Palliative Care | 1 | 2023 | 3644 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3586 | 0.020 |
Why?
|
Child | 1 | 2016 | 80863 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2021 | 3237 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1797 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2014 | 1322 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13324 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10647 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1891 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10125 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7246 | 0.010 |
Why?
|
Graft Survival | 1 | 2014 | 3890 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23839 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3145 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4425 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10273 | 0.010 |
Why?
|
Mental Health | 1 | 2016 | 3271 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6521 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18388 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8635 | 0.010 |
Why?
|
Mental Disorders | 1 | 2019 | 6879 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 30179 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 22293 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24311 | 0.010 |
Why?
|
Brain | 1 | 2020 | 27438 | 0.010 |
Why?
|
Animals | 1 | 2020 | 169418 | 0.000 |
Why?
|